M&A Deal Summary |
|
---|---|
Date | 2021-01-07 |
Target | Oxford Immunotec Global |
Sector | Medical Products |
Buyer(s) | Revvity |
Deal Type | Add-on Acquisition |
Deal Value | 591M USD |
Advisor(s) | Perella Weinberg Partners (Financial) Covington & Burling (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1937 |
Sector | Medical Products |
Employees | 11,000 |
Revenue | 2.8B USD (2023) |
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formerly known as PerkinElmer. The Company was formed in 1937 and is based in Waltham, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 32 of 36 |
Sector (Medical Products) | 9 of 11 |
Type (Add-on Acquisition) | 30 of 34 |
Country (United Kingdom) | 2 of 3 |
Year (2021) | 1 of 5 |
Size (of disclosed) | 4 of 10 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-11-02 |
Horizon Discovery Group
Cambridge, United Kingdom Horizon Discovery Group PLC is an international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines. Horizon Discovery Group was founded in 2007 and is based in Cambridge, the United Kingdom. |
Buy | £296M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-05-12 |
Nexcelom Bioscience
Lawrence, Massachusetts, United States Nexcelom Bioscience is a designer, manufacturer, and marketer of innovative Cellometer and Celigo image cytometry products designed for cell analysis in life science and biomedical research. Nexcelom Bioscience was founded in 2003 and is based in Lawrence, Massachusetts. |
Buy | $260M |